Characteristics | Values |
---|---|
Patients with a history of vaccination with PPSV23 | 88 (67.7) |
Time since vaccination, mos, mean (range) | 45 (0–180) |
Biologic treatment | |
Infliximab | 59 (45.4) |
Etanercept | 21 (16.2) |
Adalimumab | 16 (12.3) |
Tocilizumab | 17 (13.1) |
Duration of biologic treatment, mos, mean (range) | 43.4 (1–192) |
Methotrexate | 54 (41.5) |
Steroids | 25 (19.4) |
Steroid dose, mean (range) | 7.3 (1–20) |
DMARD: disease-modifying antirheumatic drug; PPSV23: pneumococcal polysaccharide vaccine 23.